Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1991 1
1994 2
1996 1
1999 2
2001 1
2003 2
2004 1
2005 3
2006 2
2007 1
2008 6
2009 4
2010 5
2011 11
2012 11
2013 21
2014 25
2015 28
2016 27
2017 36
2018 31
2019 36
2020 59
2021 74
2022 18
Text availability
Article attribute
Article type
Publication date

Search Results

368 results
Results by year
Filters applied: . Clear all
Page 1
Experimental animal models for rheumatoid arthritis.
Choudhary N, Bhatt LK, Prabhavalkar KS. Choudhary N, et al. Immunopharmacol Immunotoxicol. 2018 Jun;40(3):193-200. doi: 10.1080/08923973.2018.1434793. Epub 2018 Feb 12. Immunopharmacol Immunotoxicol. 2018. PMID: 29433367 Review.
Pathophysiological mechanisms underlying MAFLD.
Kuchay MS, Choudhary NS, Mishra SK. Kuchay MS, et al. Among authors: choudhary ns. Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1875-1887. doi: 10.1016/j.dsx.2020.09.026. Epub 2020 Sep 24. Diabetes Metab Syndr. 2020. PMID: 32998095 Review.
Reply.
Yadav SK, Choudhary NS, Soin AS. Yadav SK, et al. Among authors: choudhary ns. Liver Transpl. 2020 Dec;26(12):1669-1671. doi: 10.1002/lt.25809. Epub 2020 Aug 6. Liver Transpl. 2020. PMID: 32488978 No abstract available.
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial).
Kuchay MS, Krishan S, Mishra SK, Farooqui KJ, Singh MK, Wasir JS, Bansal B, Kaur P, Jevalikar G, Gill HK, Choudhary NS, Mithal A. Kuchay MS, et al. Among authors: choudhary ns. Diabetes Care. 2018 Aug;41(8):1801-1808. doi: 10.2337/dc18-0165. Epub 2018 Jun 12. Diabetes Care. 2018. PMID: 29895557 Clinical Trial.
Rituximab.
Borker A, Choudhary N. Borker A, et al. Among authors: choudhary n. Indian Pediatr. 2011 Aug;48(8):627-32. doi: 10.1007/s13312-011-0098-6. Indian Pediatr. 2011. PMID: 21918268 Review.
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial.
Soin AS, Kumar K, Choudhary NS, Sharma P, Mehta Y, Kataria S, Govil D, Deswal V, Chaudhry D, Singh PK, Gupta A, Agarwal V, Kumar S, Sangle SA, Chawla R, Narreddy S, Pandit R, Mishra V, Goel M, Ramanan AV. Soin AS, et al. Among authors: choudhary ns. Lancet Respir Med. 2021 May;9(5):511-521. doi: 10.1016/S2213-2600(21)00081-3. Epub 2021 Mar 4. Lancet Respir Med. 2021. PMID: 33676589 Free PMC article. Clinical Trial.
368 results